7 patents
Utility
Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss
19 Sep 23
The invention provides compositions and methods for reducing the volume of menstrual blood loss in a patient, such as a human patient, for instance, that has uterine fibroids, by administration of a gonadotropin-releasing hormone (GnRH) antagonist.
Ernest Loumaye, Jean-Pierre Gotteland, Oliver Pohl
Filed: 5 Jun 18
Utility
Method for treating post-prandial hypoglycemia
7 Mar 23
Disclosed herein are methods, sodium-dependent glucose transporter (SGLT)1 compounds and compositions for the treatment of postprandial hypoglycemia, postprandial hypoglycemia that occurs as a consequence of gastric surgery.
William Wilkison, Bentley Cheatham, James T. Green
Filed: 28 Mar 19
Utility
Usage and dosage of therapeutic agents for endometriosis
12 Jul 22
An object of the present invention is to provide pharmaceutical agents that reduce risk for decrease in bone mineral density due to their effect of reducing estrogen levels and exert excellent therapeutic effects on endometriosis.
Takuro Dan, Hideomi Takahashi, Yu Kuramochi
Filed: 8 Apr 20
Utility
Pyrrolidine derivative
4 May 21
Atsushi Kondo, Naohide Morita, Takehiro Ishikawa, Masako Yoshida, Akihiro Moriyama, Isao Wanajo
Filed: 20 Jul 17
Utility
Genetically-modified cells and method for producing same
15 Jun 20
Production of a chimeric antigen receptor (CAR) expressing cell having excellent target cytotoxicity.
Yozo Nakazawa, Kazuyuki Matsuda, Shigeru Nakano
Filed: 14 Sep 17
Utility
Usage and dosage of therapeutic agents for endometriosis
11 May 20
An object of the present invention is to provide pharmaceutical agents that reduce risk for decrease in bone mineral density due to their effect of reducing estrogen levels and exert excellent therapeutic effects on endometriosis.
Takuro Dan, Hideomi Takahashi, Yu Kuramochi
Filed: 6 Aug 17
Utility
Salt of fused heterocyclic derivative and crystal thereof
2 Mar 20
The present invention provides 3-[2-fluoro-5-(2,3-difluoro-6-methoxybenzyl-oxy)-4-methoxyphenyl]-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid choline salt having excellent solubility and storage stability.
Kazumichi Jo, Hideki Takeuchi
Filed: 26 Jun 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first